Patient Access to Disposable Medical Technology Act of 2015

H.R. 1018/S. 1253, the "Patient Access to Disposable Medical Technology Act of 2015" H.R. 1516/S. 1013, the "Ensuring Access to Quality Complex Rehabilitation Technology Act" H.R. 2646, the "Helping Families in Mental Health Crisis Act" The "Community Choice Act" Implementation of P.L. 111-148, the "Patient Protection and Affordable Care Act" HHS Appropriations: "Lifespan Respite" funding

Client expense: $66,363 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)

IPAB Repeal (HR 1190 / S 141); Medical Liability Reform (HR 4771); Medicare physician payment / SGR (HR 2); Medicare Therapeutic Shoes program for persons with diabetes (HR 1221 / S 626); Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Medicaid access to podiatry (HR 1221 / S 626); Medicaid program integrity (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270; S 2425; S 2511); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526, S 2368); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018; HR 2029); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661)

Client expense: $140,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)

H.R. 1018/ S. 1253, the Patient Access to Disposable Medical Technology Act of 2015 H.R. 1516/ S. 1013, the Ensuring Access to Quality Complex Rehabilitation Technology Act H.R. 2646, the Helping Families in Mental Health Crisis Act The Community Choice Act Implementation of P.L. 111-148, the Patient Protection and Affordable Care Act HHS Appropriations: Lifespan Respite funding

Client expense: $68,250 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)

H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015, all provisions S. 141, Protecting Seniors' Access to Medicare Act of 2015, all provisions H.R. 2102, Medicare Diabetes Prevention Act of 2015, all provisions S. 1131, Medicare Diabetes Prevention Act of 2015, all provisions H.R. 169, Critical Access Hospital Relief Act of 2015, all provisions S. 258, Critical Access Hospital Relief Act of 2015, all provisions H.R. 2513, Promoting Access, Competition, and Equity (PACE) Act of 2015, all provisions S. 2153, Provider Payment Sunshine Act, all provisions S. 2425, Patient Access and Medicare Protection Act, all provisions H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015, all provisions H.R. 3309, Flex-IT 2 Act, all provisions H.R. 976, Patient Access to Higher Quality Health Care Act of 2015, all provisions H.R. 1018, Patient Access to Disposable Medical Technology Act of 2015, all provisions H.R. 2568, Fair Medical Audits Act of 2015, all provisions H.R. 169, Critical Access Hospital Relief Act of 2015, all provisions H.R. 3940, Meaningful Use Hardship Relief Act of 2015, all provisions S. 2141, Transparent Ratings on Usability and Security to Transform Information Technology (TRUST IT) Act of 2015, all provisions S. 2368, Audit & Appeals Fairness, Integrity, and Reforms in Medicare Act of 2015, all provisions H.R. 1470, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, all provisions S. 810, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, all provisions H. R.2 - Medicare Access and CHIP Reauthorization Act of 2015, all provisions S. 843, Improving Access to Medicare Coverage Act of 2015, all provisions H.R. 3770, End Surprise Billing Act of 2015, all provisions Medicare program: Protecting Access to Medicare Act (PAMA) implementation Medicare program: MACRA Implementation/Alternate payment models Medicare program: ACA implementation/Marketplace open enrollment Medicare program: Independent Payment Advisory Board Repeal (IPAB) Medicare program: Misvalued Codes Medicare program: Meaningful Use Regulations/Electronic Health Records Medicare program: Electronic Health Records (EHR) interoperability and certification Medicare program: Telehealth and Medicare coverage Medicare program: Sequestration Medicare program: Comprehensive Joint Replacement Initiative Medicare program: In-Office Ancillary Services Exception (IOASE) Medicare program: Merit-Based Incentive Payment System (MIPS) Medicare program: Value-Based Payment Modifier (VPM) Medicare program: Graduate Medical Education (GME) Medicare program: Meaningful Use/hardship exemptions and Stage 3 regulations Medicare program: Prescription Drug Diversion Medicare program: Physician data Medicare program: Clinical Diagnostic Laboratory Tests Payment System Medicare program: Physician Quality Reporting System (PQRS) Medicare program: Drugs of Abuse Testing Medicare program: Program Integrity Medicare program: Recovery Audit Contracting (RAC) Medicare program: Mental health and HIPAA privacy law Medicare program: Chronic care Medicare program: Medicare Advantage/narrow networks Medicare program: Pre-diabetes Medicare program: Hypertension Medicare program: Drug pricing Medicare program: Relative Value Scale Update Committee (RUC) Medicaid program: Medicaid expansion Medicaid program: CPT Medicare and Medicaid programs: ICD-10

Client expense: $4,530,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

Lobbying related to Medicare Part D drug rebate proposals. Patient Access to Disposable Medical Technology Act (H.R. 1018; S. 1253) and similar provision contained in the 21st Century Cures Act (H.R. 6) and in the Consolidated Appropriations Act, 2016 (H.R. 2029).

Client expense: $410,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Assist client with work on H.R. 1018 and S. 1253, Patient Access to Disposable Medical Technology Act of 2015, H.R. 6, 21st Century Cures Act and H.R. 2029, Consolidated Appropriations Act of 2016

Client expense: Not reported · Firm income: Not reported

H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015, all provisions S. 141, Protecting Seniors' Access to Medicare Act of 2015, all provisions H.R. 2102, Medicare Diabetes Prevention Act of 2015, all provisions S. 1131, Medicare Diabetes Prevention Act of 2015, all provisions H.R. 169, Critical Access Hospital Relief Act of 2015, all provisions S. 258, Critical Access Hospital Relief Act of 2015, all provisions H.R. 2513, Promoting Access, Competition, and Equity (PACE) Act of 2015, all provisions S. 2153, Provider Payment Sunshine Act, all provisions S. 2425, Patient Access and Medicare Protection Act, all provisions H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015, all provisions H.R. 3309, Flex-IT 2 Act, all provisions H.R. 976, Patient Access to Higher Quality Health Care Act of 2015, all provisions H.R. 1018, Patient Access to Disposable Medical Technology Act of 2015, all provisions H.R. 2568, Fair Medical Audits Act of 2015, all provisions H.R. 169, Critical Access Hospital Relief Act of 2015, all provisions H.R. 3940, Meaningful Use Hardship Relief Act of 2015, all provisions S. 2141, Transparent Ratings on Usability and Security to Transform Information Technology (TRUST IT) Act of 2015, all provisions S. 2368, Audit & Appeals Fairness, Integrity, and Reforms in Medicare Act of 2015, all provisions H.R. 1470, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, all provisions S. 810, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, all provisions H. R.2 - Medicare Access and CHIP Reauthorization Act of 2015, all provisions S. 843, Improving Access to Medicare Coverage Act of 2015, all provisions H.R. 3770, End Surprise Billing Act of 2015, all provisions Medicare program: Protecting Access to Medicare Act (PAMA) implementation Medicare program: MACRA Implementation/Alternate payment models Medicare program: ACA implementation/Marketplace open enrollment Medicare program: Independent Payment Advisory Board Repeal (IPAB) Medicare program: Misvalued Codes Medicare program: Meaningful Use Regulations/Electronic Health Records Medicare program: Electronic Health Records (EHR) interoperability and certification Medicare program: Telehealth and Medicare coverage Medicare program: Sequestration Medicare program: Comprehensive Joint Replacement Initiative Medicare program: In-Office Ancillary Services Exception (IOASE) Medicare program: Merit-Based Incentive Payment System (MIPS) Medicare program: Value-Based Payment Modifier (VPM) Medicare program: Graduate Medical Education (GME) Medicare program: Meaningful Use/hardship exemptions and Stage 3 regulations Medicare program: Prescription Drug Diversion Medicare program: Physician data Medicare program: Clinical Diagnostic Laboratory Tests Payment System Medicare program: Physician Quality Reporting System (PQRS) Medicare program: Drugs of Abuse Testing Medicare program: Program Integrity Medicare program: Recovery Audit Contracting (RAC) Medicare program: Mental health and HIPAA privacy law Medicare program: Chronic care Medicare program: Medicare Advantage/narrow networks Medicare program: Pre-diabetes Medicare program: Hypertension Medicare program: Drug pricing Medicare program: Relative Value Scale Update Committee (RUC) Medicaid program: Medicaid expansion Medicaid program: CPT Medicare and Medicaid programs: ICD-10

Client expense: $4,490,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

Issues related to disposable medical technologies and H.R. 1018, the Patient Access to Technology Act of 2015; issues related to S.1253, The Patient Access to Disposable Medical Technology Act of 2015.

Client expense: Not reported · Firm income: $54,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R 1018: Patient Access to Disposable Medical Technology Act H.R. 1600: Patients Access to Treatments Act H.R. 2570: Strengthening Medicare Advantage through Innovation and Transparency Act for Seniors of 2015 S. 1253: Patient Access to Disposable Medical Technology Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

Client expense: $510,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Guard, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection

H.R. 1018/S. 1253, Patient Access to Disposable Medical Technology.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES

S.1253, H.R. 1018, Patient Access to Disposable Medical Technology Act of 2015; 21st Century Cures Act.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

IPAB Repeal (HR 1190 / S 141); Medical Liability Reform; Medicare physician payment / SGR (HR 2; HR 1470; S 810); Medicare Therapeutic Shoes program for persons with diabetes; Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Medicaid access to podiatry (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270; S 2425); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018; HR 2029); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661)

Client expense: $140,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)

H.R. 1018/ S. 1253, the Patient Access to Disposable Medical Technology Act of 2015 H.R. 1516/ S. 1013, the Ensuring Access to Quality Complex Rehabilitation Technology Act H.R. 2646, the Helping Families in Mental Health Crisis Act The Community Choice Act Implementation of P.L. 111-148, the Patient Protection and Affordable Care Act HHS Appropriations: Lifespan Respite funding

Client expense: $62,998 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)

Supports S.849 - Advancing Research for Neurological Diseases Act of 2015. This bill will mandate that the Centers for Disease Control and Prevention track the incidence and prevalence of neurological diseases. Also support the companion bill, HR 292 (which was included in the 21st Century Cures Initiative). United Spinal supports the Patient Access to Disposable Medical Technology Act of 2015, S.1253/H.R. 1018 - portable medical equipment that can be used outside of the hospital. United Spinal joined a coalition, led by the Center for Responsible Science, to file an FDA petition to broaden testing options in drug development and to update regulations that govern preclinical drug and device development. As a member of the Patients for Biologics Safety and Access, United Spinal is engaged in an advocacy campaign with Congress to ensure that Congress hold an oversight hearing with the Food and Drug Administration to ask for expedited publication of guidances on consumer safety and clinical testing for biological pharmaceuticals. A Senate HELP hearing with the FDA CDRH Director, Janet Woodcock testifying took place in September. United Spinal Association signed on to a letter spearheaded by the Advanced Medical Technology Association (AdvaMed) in support of repealing the tax on medical device manufacturers. Research shows that innovations in medical technology have greatly improved outcomes of individuals with disabilities. We are concerned that the medical device tax will curtail investments in future innovation, thereby reducing consumer access to innovative medicine and hampering their quality of life.

Client expense: Not reported · Firm income: $75,000

Government targets: Defense, Dept of (DOD), Education, Dept of, Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Transportation, Dept of (DOT), Veterans Affairs, Dept of (VA), White House Office

Issues related to disposable medical technologies and H.R. 1018, the Patient Access to Technology Act of 2015; issues related to S.1253, The Patient Access to Disposable Medical Technology Act of 2015.

Client expense: Not reported · Firm income: $54,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Supports S.849 - Advancing Research for Neurological Diseases Act of 2015. This bill will mandate that the Centers for Disease Control and Prevention track the incidence and prevalence of neurological diseases. Also support the companion bill, HR 292 (which was included in the 21st Century Cures Initiative). United Spinal supports the Patient Access to Disposable Medical Technology Act of 2015, S.1253/H.R. 1018 - portable medical equipment that can be used outside of the hospital. United Spinal joined a coalition, led by the Center for Responsible Science, to file an FDA petition to broaden testing options in drug development and to update regulations that govern preclinical drug and device development. As a member of the Patients for Biologics Safety and Access, United Spinal is engaged in an advocacy campaign with Congress to ensure that Congress hold an oversight hearing with the Food and Drug Administration to ask for expedited publication of guidances on consumer safety and clinical testing for biological pharmaceuticals. A Senate HELP hearing with the FDA CDRH Director, Janet Woodcock testifying took place in September. United Spinal Association signed on to a letter spearheaded by the Advanced Medical Technology Association (AdvaMed) in support of repealing the tax on medical device manufacturers. Research shows that innovations in medical technology have greatly improved outcomes of individuals with disabilities. We are concerned that the medical device tax will curtail investments in future innovation, thereby reducing consumer access to innovative medicine and hampering their quality of life.

Client expense: Not reported · Firm income: $75,000

Government targets: Defense, Dept of (DOD), Education, Dept of, Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Transportation, Dept of (DOT), Veterans Affairs, Dept of (VA), White House Office

HR 1600: Patients' Access to Treatments Act S 1253: Patients' Access to Disposable Medical Technologies Act HR 1018: Patients' Access to Disposable Medical Technologies Act HR 2570: Strengthening Medicare Advantage through Innovation and Transparency for Seniors Act of 2015

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Supports S.849 - Advancing Research for Neurological Diseases Act of 2015. This bill will mandate that the Centers for Disease Control and Prevention track the incidence and prevalence of neurological diseases. Also support the companion bill, HR 292 (which was included in the 21st Century Cures Initiative). United Spinal supports the Patient Access to Disposable Medical Technology Act of 2015, S.1253/H.R. 1018 - portable medical equipment that can be used outside of the hospital. United Spinal joined a coalition, led by the Center for Responsible Science, to file an FDA petition to broaden testing options in drug development and to update regulations that govern preclinical drug and device development. As a member of the Patients for Biologics Safety and Access, United Spinal is engaged in an advocacy campaign with Congress to ensure that Congress hold an oversight hearing with the Food and Drug Administration to ask for expedited publication of guidances on consumer safety and clinical testing for biological pharmaceuticals. A Senate HELP hearing with the FDA CDRH Director, Janet Woodcock testifying took place in September. United Spinal Association signed on to a letter spearheaded by the Advanced Medical Technology Association (AdvaMed) in support of repealing the tax on medical device manufacturers. Research shows that innovations in medical technology have greatly improved outcomes of individuals with disabilities. We are concerned that the medical device tax will curtail investments in future innovation, thereby reducing consumer access to innovative medicine and hampering their quality of life.

Client expense: Not reported · Firm income: $75,000

Government targets: Defense, Dept of (DOD), Education, Dept of, Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Transportation, Dept of (DOT), Veterans Affairs, Dept of (VA), White House Office

Assist client with work on H.R. 1018 and S. 1253, Patient Access to Disposable Medical Technology Act of 2015, and H.R. 6, 21st Century Cures Act

Client expense: Not reported · Firm income: Not reported

Lobbying related to Medicare Part D drug rebate proposals. Patient Access to Disposable Medical Technology Act (H.R. 1018; S. 1253) and similar provision contained in the 21st Century Cures Act (H.R. 6). CY 2016 Medicare Hospital Outpatient Proposed Rule.

Client expense: $360,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

Client expense: $580,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Guard, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection

H.R. 1600: Patient's Access to Treatments Act H.R 1018: Patient Access to Disposable Medical Technology Act S. 1253: Patient Access to Disposable Medical Technology Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare coverage and payment for durable medical equipment; H.R. 1018/S. 1253, Patient Access to Disposable Medical Technology; H.R. 6, 21st Century Cures, provision related to disposable medical technology.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES

Issues related to Medicare Home infusion legislation, H.R.605/S.275 - Medicare Home Infusion Site of Care Act of 2015. H.R.1018 - Patient Access to Disposable Medical Technology Act of 2015.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.1253, H.R. 1018, Patient Access to Disposable Medical Technology Act of 2015; 21st Century Cures Act.

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

IPAB Repeal (HR 1190 / S 141); Medical Liability Reform; Medicare physician payment / SGR (HR 2; HR 1470; S 810); Medicare Therapeutic Shoes program for persons with diabetes; Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Medicaid access to podiatry (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661)

Client expense: $140,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)

H.R. 1018, the Patient Access to Disposable Medical Technology Act of 2015 H.R. 1516, the Ensuring Access to Quality Complex Rehabilitation Technology Act H.R. 2646, the Helping Families in Mental Health Crisis Act The Community Choice Act Implementation of P.L. 111-148, the Patient Protection and Affordable Care Act HHS Appropriations: Lifespan Respite funding

Client expense: $62,546 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)

S.1253, H.R. 1018, Patient Access to Disposable Medical Technology Act of 2015; 21st Century Cures Act.

Client expense: Not reported · Firm income: Not reported

Lobbying related to Medicare policies that promote bundled payments. Lobbying related to implementation of the ICD-10 coding system. Lobbying related to Medicare Part D drug rebate proposals. Patient Access to Disposable Medical Technology Act (H.R. 1018; S. 1253) and similar provision contained in the 21st Century Cures Act (H.R. 6).

Client expense: $380,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 6: 21st Century Cures Act HR 1600: Patients' Access to Treatments Act S 1253: Patients' Access to Disposable Medical Technologies Act HR 1018: Patients' Access to Disposable Medical Technologies Act

Client expense: $100,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to disposable medical technologies and H.R. 1018, the Patient Access to Technology Act of 2015; issues related to S.1253, The Patient Access to Disposable Medical Technology Act of 2015.

Client expense: Not reported · Firm income: $54,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Assist client with work on H.R. 1018, Patient Access to Disposable Medical Technology Act of 2015; and H.R. 6, 21st Century Cures Act.

Client expense: Not reported · Firm income: $40,000

Issues related to disposable medical technologies and H.R. 1018, the Patient Access to Technology Act of 2015; issues related to S.1253, The Patient Access to Disposable Medical Technology Act of 2015.

Client expense: Not reported · Firm income: $54,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare coverage and payment for durable medical equipment; H.R. 1018/S. 1253, Patient Access to Disposable Medical Technology; H.R. 6, 21st Century Cures, provision related to disposable medical technology.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES

H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015, H.R.1018/S.1253, Patient Access to Disposable Medical Technology Act of 2015, H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.

Client expense: $520,000 · Firm income: Not reported

Government targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Guard, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection

Supports H.R. 1516/S. 1013 - ENsuring Access to Quality Compex Rehabiliation Technology Act - to ensure Medicare beneficiaries' access to customized wheelchairs. United Spinal advocated distributed a Congressional Dear Colleague letter urging that CRT accessories (specialty controls such as head-rests) are not set at competitive bidding pricing the same as standard wheelchairs due to their highly customized nature for a small population living with significant disabilities. United Spinal highlighted our concern with CRT Accessories, described above and with our concerns with access to durable medical equipment for wheelchair users under the competitive acquisition program. United Spinal signed on to a letter to US Health and Human Services Secretary Burwell and CMS officials regarding a pending case, Davis v. Shah, in the U.S. Second Circuit Court of Appeals - a challenge to New York Medicaid's attempt to limit coverage of compression stockings and orthopedic shoes only to Medicaid recipients with specific diagnoses. Supports the Steve Gleason Act which lifts caps on access to speech-generating devices. (HR 1919, H.R. 629, S, 768, S. 984. United Spinal supported Congressional testimony on behalf of the Coalition to Preserve Rehabilitation Steering Committee highlighting the need to eliminate site-neutral payments under Medicare and also advocated for additional signatories to a Dear Colleague letter stating the same issue. United Spinal supports expanded state participation in Medicaid programs that increase funding for HCBS such as the Community First Choice Option, Money Follows the Person, and the Balancing Incentive Program; and oppose restructuring of Medicaid funding through block grants, State Flexibility Funds, or per capita caps. United Spinal signed on to a letter to the Centers for Medicare and Medicaid Services in support of an improved mechanism for the reimbursement of Lemtrada to ensure speedier access to this therapy for individuals with multiple sclerosis. United Spinal signed onto three comment letters to the Centers for Medicare and Medicaid Services in support of improved rehab policy, namely: on in-patient rehabilitative facilities and on skilled nursing facilities to allow for improved quality reporting and on acute care hospitals and payment issues to ensure that bundled payments of services does not hinder coverage of episodes of care for individuals with multiple needs. United Spinal signed onto a MapRx letter to urge the Senate Finance Committee to include, in their discussion of chronic care, robust formularies, coverage of the six-protected classes of drugs, strong oversight, and transparency for consumers are among the design principles essential to meet the needs of Medicare beneficiaries. In addition, a process for notice of non-coverage, appeals and exceptions is critical to providing access to needed drug therapies. United Spinal supports S.1253, the Patient Access to Disposable Medical Technology Act of 2015.The legislation amends title XVIII (Medicare) of the Social Security Act to cover disposable medical technology in addition to equipment traditionally described as durable medical equipment. This legislation was introduced by Senators Burr (R-NC) and Bennet (D-CO) this spring and is identical to its House counterpart, H.R. 1018, which United Spinal has also supported. United Spinal supports the Protect Medical Innovation Act of 2015, HR 160, introduced by Rep. Eric Paulsen of Minnesota, which repeals the medical device tax on medical device manufacturers and importers. United Spinal signed on to a letter to Congress to convey support for the goals of the final Home and Community Based Settings (HCBS) rule issued by the Centers for Medicare & Medicaid Services (CMS) in January 2014. This rule is the first time CMS has defined community for Medicaid-funded HCBS programs. The letter also urges Congress to: protect cuts to funding; support the requested additional $2.8m in CMS funding for HCBS; and defend against policies or changes to the rule that would hinder the goal of providing supports through HCBS so that people with disabilities can live meaningful lives.

Client expense: Not reported · Firm income: $120,000

Government targets: Defense, Dept of (DOD), Education, Dept of, Federal Communications Commission (FCC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Transportation, Dept of (DOT), U.S. Architectural & Transportation Barriers Compliance Board (ACCESS), U.S. Coast Guard (USCG), Veterans Affairs, Dept of (VA), White House Office

H.R. 1600: Patient's Access to Treatments Act H.R 1018: Patient Access to Disposable Medical Technology Act S. 1253: Patient Access to Disposable Medical Technology Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare Home infusion legislation, H.R.605/S.275 - Medicare Home Infusion Site of Care Act of 2015. H.R.1018 - Patient Access to Disposable Medical Technology Act of 2015.

Client expense: Not reported · Firm income: $24,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1018, the Patient Access to Disposable Medical Technology Act of 2015 H.R. 1516, the Ensuring Access to Quality Complex Rehabilitation Technology Act Implementation of P.L. 111-148, the Patient Protection and Affordable Care Act HHS Appropriations: Lifespan Respite funding

Client expense: $65,911 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)

IPAB Repeal (HR 1190 / S 141); Medical Liability Reform; Medicare physician payment / SGR (HR 2; HR 1470; S 810); Medicare Therapeutic Shoes program for persons with diabetes; Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Veterans Admin. provider recruitment, retention and reimbursement; Medicaid access to podiatry (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661); student loan assistance (HR 1707)

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Lobbying related to Medicare policies that promote bundled payments. Lobbying related to implementation of the ICD-10 coding system. Lobbying related to Medicare Part D drug rebate proposals. Patient Access to Disposable Medical Technology Act (H.R. 1018) and 21st Century Cures legislation. CY 2015 Medicare final rule for hospital outpatient prospective payment system and ambulatory surgical center payment system: Provisions related to packaging of drugs and biologicals.

Client expense: $460,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1600: Patients' Access to Treatments Act Medicare Reimbursement for Neurological Diagnostic Testing HR 1018: Patients' Access to Disposable Medical Technologies Act Implementation of Drug Quality and Security Act

Client expense: $130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare Home infusion legislation, Medicare Home Infusion Site of Care Act. H.R.1018 - Patient Access to Disposable Medical Technology Act of 2015

Client expense: Not reported · Firm income: $24,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Assist client with work on H.R. 1018, Patient Access to Disposable Medical Technology Act of 2015.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES